Find Academic Supervisors

• Mathematical Analysis
• Fuzzy Set Theory
• Measure Theory
• +5 more

Lect. dr. Alina Cristiana Gavriluţ is a faculty member at the Faculty of Mathematics, Al. I. Cuza University of Iaşi, Romania. Her research focuses on advanced topics in mathematical analysis, including set multifunctions, non-additive measures, fuzzy integrals, and their applications in physics and complex systems. She has authored/co-authored multiple books and over 30 peer-reviewed papers in journals like Fuzzy Sets and Systems , Entropy , and Reports on Mathematical Physics . Her work explores regularity properties of set multifunctions, integrability in non-additive settings, and interdisciplinary applications in areas like fractal information, quantum mechanics, and neurosciences. She has also contributed to theoretical frameworks connecting mathematical physics with complex systems, including studies on non-differentiable entropy and spacetime manifolds. Dr. Gavriluţ collaborates extensively with researchers in mathematics and physics, notably Maricel Agop and Anca Croitoru. Her research has implications for diverse fields, from image processing to neuronal network modeling. She actively participates in international conferences, presenting findings on set-valued integration, fractal systems, and transdisciplinary approaches to complex phenomena. Education: PhD in Mathematics from Al. I. Cuza University (year not specified). Key Areas: Mathematical analysis, measure theory, fuzzy set theory, complex systems, non-differentiable dynamics. Grants/Awards: Not explicitly listed in the provided texts, but her prolific publication record indicates sustained academic engagement. Labs/Teams: Affiliated with the Mathematics department at Al. I. Cuza University, contributing to research groups in functional analysis and mathematical physics.

Andrew GordusView profile

Assistant Professor

• Cellular Neuroscience
• Molecular Neuroscience
• Neural Circuits
• +13 more

Andrew Gordus is an Assistant Professor in the Department of Biology at Johns Hopkins University, with affiliations in the Neuroscience Training Program and the Cellular, Molecular, Developmental and Biophysics (CMDB) Graduate Program. He leads an active research laboratory focused on the neural and genetic basis of behavior using model organisms such as C. elegans and the spider Uloborus diversus . His research centers on understanding how neural circuits generate both novel and innate behaviors in response to environmental variability. Using genetic, imaging, and behavioral tools, his lab investigates decision-making, motor control, and sensory integration in these organisms. Notably, they study the precise movement sequences in spider web-building and stochastic foraging behaviors in worms. The lab's recent publications reveal a strong emphasis on neural circuit dynamics , behavioral algorithms , genetic tools development , and systems neuroscience , often combining molecular genetics with quantitative behavioral analysis. Their work appears in high-impact journals such as Current Biology , eLife , and PNAS . NSF Division of Physics grant (2023) NIGMS R35 grant renewal (2023) JHU Catalyst Award (2022) Buck Institute Nathan Shock Center grant (2022) NSF Postdoctoral Fellowship (mentored awardee) Gordus mentors a diverse group of graduate students, postdocs, and undergraduates, and supports their professional development. His lab culture emphasizes diversity, equity, and inclusion, welcoming scientists from immigrant, LGBTQ+, Black, Jewish, Latino, and Asian backgrounds. The lab is supported by multiple competitive grants and actively contributes to advancing the understanding of how brains generate complex behaviors.

Yasir ZakiView profile

Assistant Professor

• Communication Networks
• Wireless Networks
• Cellular Communication
• +9 more

Yasir Zaki is an Assistant Professor of Computer Science at New York University Abu Dhabi and a Global Network Assistant Professor at the Courant Institute of Mathematical Sciences, NYU. He leads the Communication Networks Lab, focusing on next-generation communication systems, performance optimization, and digital equity. University: New York University Abu Dhabi School: Courant Institute of Mathematical Sciences Department: Department of Computer Science Academic Rank: Assistant Professor Email: yz48@nyu.edu Dr. Zaki holds an MSc and PhD in Communication and Information Technology from the University of Bremen, graduating with honors. His research centers on communication and wireless networks, cellular systems, congestion control, and enhancing internet access in developing regions. His work bridges theory and real-world impact, especially in digital inclusion and AI's role in education. His recent publications span top venues like PNAS, IEEE TCSS, and ACM IMC, covering topics such as satellite network performance, digital inequality (Lite-Web), AI in education, and Big Tech's global influence. These works reveal a strong trend toward socially impactful computing, network measurement at scale, and algorithmic transparency. Big Tech Dominance Despite Global Mistrust Perception of AI in Education YouTube's Political Bias Lite-Web for Digital Equity Satellite Network Analysis His research has been recognized through high-profile media coverage in Nature and The National , and his PhD student Hazem Ibrahim received the MIT Technology Review Arabia’s Innovators Under 35 MENA 2023 award. This reflects the lab's excellence in computational social science and AI policy. Dr. Zaki mentors students in the Capstone and Research Seminar courses and actively advises PhD and research assistants. He has secured research funding through NYUAD and collaborative projects, enabling field deployments in 56 countries. His lab, the Communication Networks Lab, fosters interdisciplinary work, involving researchers from computer science, social sciences, and policy.

• Molecular Pharmacology
• Cardiovascular Signaling
• Congenital Heart Disease
• +7 more

Sravan Perla is an Associate Research Scientist in the Department of Pharmacology at Yale School of Medicine, where he conducts research under the mentorship of Dr. Anton Bennett. His work focuses on elucidating the molecular mechanisms of Protein Tyrosine Phosphatases (PTPs) in congenital heart diseases and metabolic regulation. Education: Ph.D. in Molecular Medicine and Pathology from New York Medical College and the University of Toledo; M.Sc. in Medical Biochemistry from JIPMER, India; B.Sc. in Biochemistry from Silver Jubilee Govt. Degree College. His primary research interests include cardiovascular signaling pathways , particularly the PZR/Shp2/Irx3/Irx5/BMP10 axis in Noonan Syndrome and related disorders. He investigates epigenetic regulation of genes like angiotensinogen and explores therapeutic interventions such as low-dose dasatinib and recombinant BMP10 for hypertrophic cardiomyopathy. His work bridges molecular pharmacology and translational medicine. The recent publications highlight a strong trend in signal transduction , cardiovascular pathophysiology , and therapeutic repurposing , with a focus on tyrosine phosphatases and TGF-β pathways. His research also extends into neurological applications, as seen in his co-authored work on post-stroke seizures. Best Poster Presentation , Yale Center for Molecular and Systems Metabolism (YMSM), 2024 Armed Forces Medical College Quiz Award , Association of Clinical Biochemists of India, 2010 Sravan Perla actively contributes to peer review for journals including Frontiers , Healthcare-MDPI , and International Journal of Environmental Research and Public Health . He is a key member of the Bennett Laboratory , where he advances research on PTP signaling and its implications for human disease. His work is supported by institutional affiliations at Yale and collaborative networks across neuroscience and cardiology.

Hani GoodarziView profile

Associate Professor

• Computational Biology
• RNA Biology
• Cancer Genomics
• +3 more

Hani Goodarzi, PhD , is an Associate Professor in the Department of Biochemistry and Biophysics at the University of California, San Francisco (UCSF), with dual affiliation to the Arc Institute and Helen Diller Cancer Center. His laboratory employs a systems biological framework integrating computational and experimental approaches to investigate metastatic progression in cancer and neurodegenerative diseases. Princeton University PhD in Quantitative & Computational Biology Postdoctoral Fellow, Rockefeller University (Cancer Systems Biology) NIH R01 Grants (2016–2026) Research Themes : Machine learning for in silico functional genomics Evolutionary dynamics of oncRNA regulatory modules in cancer Post-transcriptional control via tiRNA fragments and RNA methylation RNA structural element discovery using pyPAGE algorithms Scientific Recognition : Vilcek Prize for Creative Promise (2022) NIH K99/R00 Award (2015) Tri-Institutional Breakout Prize (2014) Blavatnik Regional Award (2015) Laboratory Impact : Developed Deep Generative AI for early-stage lung cancer detection Identified ENPP1 as innate immune checkpoint in breast cancer Created pyPAGE framework for gene-set enrichment analysis

• Glomerulonephritis
• chronic kidney disease
• translational research
• +5 more

Dr. Edmund Chung is a Clinical Senior Lecturer at Sydney Medical School, University of Sydney, affiliated with the Children's Hospital at Westmead and the Faculty of Medicine and Health. He works as a staff specialist nephrologist at Royal North Shore Hospital and conducts postdoctoral research at the Centre for Kidney Research at The Children's Hospital at Westmead. His primary clinical and research focus is on autoimmune kidney diseases, particularly membranous nephropathy and chronic kidney disease. Dr. Chung's educational background includes: Bachelor of Medicine (BMed) Doctor of Medicine (MD) Master of Medicine in Clinical Epidemiology (MMed (Clin Epi)) - completed in 2015 Doctor of Philosophy (PhD) - completed in 2025, supported by the NHMRC Postgraduate Research Scholarship Fellow of the Royal Australasian College of Physicians (FRACP) Dr. Chung's research focuses on glomerulonephritis, chronic kidney disease, and translational research , with particular emphasis on immunological mechanisms and novel therapies. His work bridges basic science and clinical practice, exploring cellular and molecular approaches to understand and treat autoimmune kidney diseases. His laboratory investigates autoreactive T-cells and B-cells in membranous nephropathy while developing innovative treatments like CAR T-cell therapies. Dr. Chung's research program is driven by patient perspectives, as evidenced by his qualitative studies on living with membranous nephropathy, ensuring his scientific inquiries address real clinical needs and patient experiences. Dr. Chung's recent publications demonstrate a strong focus on immunological mechanisms in kidney disease, particularly membranous nephropathy. His work spans basic science investigations using animal models, clinical studies of patient cohorts, and systematic reviews that inform international guidelines. A notable trend is his exploration of cellular therapies, especially CAR T-cell approaches, for treating autoimmune kidney diseases. His research also encompasses epidemiological studies of kidney diseases in Australian populations and the development of predictive models for disease recurrence after transplantation. The interdisciplinary nature of his work is evident in collaborations spanning nephrology, immunology, oncology, and transplantation medicine. Dr. Chung has received several prestigious awards and honors: Asian Pacific Society of Nephrology/Japanese Society of Nephrology Joint Symposium Invited Talk (2024) for "Membranous nephropathy: clearer immunopathogenesis and therapeutic implications" NHMRC Postgraduate Research Scholarship (2022) for research on "Treatments to expand regulatory T cells +/- deplete autoantibody production in membranous nephropathy" American Journal of Kidney Diseases Editor's Choice Award (2022) for "Incidence and outcomes of COVID-19 in people with CKD: a systematic review and meta-analysis" Dr. Chung serves as the Knowledge Translation and Dissemination Editor for the Cochrane Kidney and Transplant Group, where he creates educational content including webinars and podcasts with the International Society of Nephrology. He is actively involved in clinical trial networks through his position on the Australasian Kidney Trial Network Glomerulonephritis Working Group, supporting investigator-initiated trials in glomerulonephritis. Additionally, he contributes to the ClinGen Glomerulopathy Working Group as a Biocurator, working to understand the genetic basis of glomerulonephritis. His research is supported by collaborations across multiple institutions and his leadership in establishing the Australian glomerulonephritis cohort (PEACH) to facilitate patient-focused research in membranous nephropathy. Dr. Chung leads research at the Centre for Kidney Research at The Children's Hospital at Westmead, where his team investigates autoreactive T-cells and B-cells in patients with membranous nephropathy. He has established the PEACH cohort (Patient Experience in Autoimmune Chronic Kidney Disease) to study membranous nephropathy, the most common form of nephrotic syndrome in adults. His laboratory work focuses on developing novel CAR T-cell therapies for autoimmune kidney diseases. Dr. Chung collaborates with immunologists, basic scientists, and clinicians across multiple institutions to advance understanding and treatment of glomerulonephritis.

• Psychology
• Public health care science
• Environmental and occupational health
• +4 more

Markus Jokela is a Professor at the University of Helsinki, Faculty of Medicine, Department of Psychology and Logopedics. His research spans psychology, public health, and behavioral epidemiology, with a focus on personality traits, mental health, and their interplay with physical health and societal factors. Field of Science: Psychology, Public health care science, Environmental and occupational health Projects: Social networks and demographic resilience, Teacher wellbeing, Fertility behavior, Genetic and environmental influences Research interests include mental health epidemiology , personality-health associations , fertility determinants , and psychosocial interventions . Recent work examines proteomic ageing signatures, depression-anxiety dynamics in digital therapy, and obesity-depression causality. Key article trends show cross-disciplinary engagement with depression subtyping , fertility intentions , entrepreneurial stress , and neighborhood effects . Subfields span from psychotherapy outcomes to metabolically healthy obesity . Scientific recognition includes: Young Researcher Award (PsykoNet, 2010) University of Helsinki Ph.D. thesis awards (2007) Honorary Research Associate, UCL (2008-) As a supervisor, he has guided doctoral candidates Venla Berg, Heini Väisänen, and Tom Rosenström, among others. His projects like NetResilience (2024-2027) and FTProWell (2016-2019) demonstrate sustained funding from the Strategic Research Council and other bodies.

• Adrenal Development
• Reproductive Development
• Transcriptomics
• +10 more

Prof John Achermann is a Clinical Professor of Paediatric Endocrinology at the Genetics & Genomic Medicine Department , University College London (UCL), with an active role at the UCL GOS Institute of Child Health since 2023. His career spans clinical and research expertise in adrenal and sex development , genetic mechanisms of disease , and nuclear receptor biology , highlighted by over 200 publications and an h-index of 67. Education: Bachelor of Arts (Honours), University of Cambridge (1988) Bachelor of Medicine, University of Cambridge (1990) Master of Arts, University of Cambridge (1992) Doctor of Medicine (MD), University of Cambridge (1997) Doctor of Philosophy (PhD), University of Cambridge (2011) His research focuses on molecular genetics of adrenal and reproductive development , integrating transcriptomics and genomic medicine to understand disorders like Turner syndrome, Disorders of Sex Development (DSD), and adrenal insufficiency. Recent work includes single-cell analyses of fetal gonads , exome sequencing for DSD/POI , and NR5A1/SRY regulatory mechanisms . Key awards include the 2025 ESPE Research Award , 2023 Henning Andersen Prize , and 2016 Clinical Endocrinology Trust Lecturer Medal . Scientific Awards: ESPE Research Award (2025) Henning Andersen Prize (2023, 2007) Clinical Endocrinology Trust Lecturer Medal (2016) SPARKS/RCPCH Young Investigator (2007) ESPE Young Investigator (2002) Noble Prize for MD Thesis (1998) As Head of the Molecular Basis of Rare Disease Section and Deputy Head of Genetics & Genomic Medicine at UCL GOS Institute of Child Health, he bridges clinical practice with translational research. He contributes to undergraduate and postgraduate medical education , supervises MSc projects, and serves on the ESPE Local Organising Committee for 2024. His work aligns with UN Sustainable Development Goals for Good Health & Well-Being and Gender Equality .

• Neurogenetics
• Movement disorders
• Pediatric neurology
• +3 more

Professor Manju Kurian is a Professor of Neurogenetics in the Developmental Neurosciences Department at University College London (UCL), based at the UCL GOS Institute of Child Health. Her research focuses on neurogenetic disorders, particularly movement disorders and neurodegenerative conditions affecting children. Her research interests span multiple areas of neurogenetics and pediatric neurology: Neurogenetics of movement disorders Neurodegenerative diseases with childhood onset Genetic therapies for neurological conditions Brain iron accumulation disorders Dystonia and Parkinsonism in children Neurotransmitter disorders Professor Kurian's research output demonstrates a strong focus on translational neuroscience, bridging genetic discoveries with clinical applications. Her work spans from basic molecular mechanisms of neurological disorders to clinical management guidelines and therapeutic interventions. A significant portion of her research addresses rare genetic movement disorders, with particular attention to conditions like PLA2G6-associated neurodegeneration, VPS16-related dystonia, and ADCY5-related disease. She has been instrumental in developing clinical assessment tools for pediatric movement disorders and exploring novel therapeutic approaches including deep brain stimulation and genetic therapies. Professor Kurian has received recognition through numerous citations of her work, with several publications gaining significant attention in the scientific community. Her 2024 Lancet Neurology paper on "Climate change and disorders of the nervous system" has been particularly influential, with 42 total citations. She actively collaborates with researchers internationally, as evidenced by her extensive co-authorship network across multiple continents. Her work involves both clinical research with patient populations and laboratory-based investigations using cellular models.

Andrew P. WojtovichView profile

Associate Professor

• Mitochondrial Physiology
• Reactive Oxygen Species (ROS) Signaling
• Optogenetics
• +5 more

Andrew P. Wojtovich, Ph.D., is an Associate Professor at the University of Rochester School of Medicine and Dentistry, with joint appointments in the Department of Anesthesiology and Perioperative Medicine and Department of Pharmacology and Physiology . His research focuses on mitochondrial physiology , redox signaling , and optogenetic control of bioenergetics in C. elegans and mammalian models. He received his Ph.D. in Pharmacology (2010) and M.S. in Pharmacology (2007) from the University of Rochester, preceded by dual B.A. and M.A. in Biochemistry and Molecular Biology from Boston University (2005). His lab is affiliated with the Mitochondrial Research and Innovation Group , Neuroscience Graduate Program , and Cellular and Molecular Pharmacology and Physiology Graduate Program . Key research areas include ROS microdomains in neuronal ischemia Protonmotive force regulation of aging Mitochondrial dysfunction in Alzheimer's disease His work is supported by NIH grants R01 NS092558 , R01 NS115906 , R56AG082916 , and R21AG085324-01 . Scientific accolades include 2023 Hypothesis Prize (3rd place) 2021 Student Supervisor of the Year Multiple University Research Awards (2015-2018) Young Investigator Awards (2007, 2012) His lab employs optogenetic tools to control mitochondrial function with precision, leading to groundbreaking insights in stroke outcomes and longevity pathways .

Susann MüllerView profile

Associate Professor

• Microbial Ecology
• Flow Cytometry
• Environmental Biotechnology
• +5 more

Prof. Dr. Susann Müller is Senior Scientist and Group Leader of the Flow Cytometry Working Group at the Department of Applied Microbial Ecology, Helmholtz Center for Environmental Research (UFZ) in Leipzig, Germany. Since 2011, she has held an Associate Professor position for Microbiology at Leipzig University’s Faculty of Life Sciences, bridging fundamental microbial ecology with environmental biotechnology applications through single-cell analytics. Education: 1985: Diploma in Biochemistry, Martin Luther University Halle-Wittenberg 1992: PhD, University of Halle-Wittenberg (Population dynamics of S. cerevisiae) 2003: Habilitation, Technical University Dresden (Multiparametric Cytometry) Her research pioneers microbial community flow cytometry to extract single-cell high-dimensional data, applying macroecological concepts to quantify stability metrics (resistance, resilience, displacement speed, elasticity) in engineered systems. Current focus includes bio-based circular economy initiatives: developing the carboxylate platform for sustainable chemical production and biological phosphate recovery from wastewater streams for resource valorization. Recent publications (2021-2025) reveal consistent innovation in flow cytometry applications, with emphasis on stability assessment in bioreactors, predator-prey dynamics in complex communities, and real-time monitoring of wastewater systems. She integrates ecological theory with multi-omics and data science to decode microbial assembly principles across environmental, agricultural, and industrial contexts. Professional roles: President, German Society of Cytometry (DGfZ, 2008-2010) Associate Editor, Microbiology for Cytometry Part A ISAC Educational Committee (2011-2012) and Scholars Program Committee (2013-2015) Current grants: PHOM project (SMWK InfraProNet 2024-2027): €449,160 for wastewater phosphorus recovery Z-PROJECT (DFG 2022-2025): €556,550 for bacterial biofilm analysis PROMICON (EU H2020 2021-2025): €200,000 for industrial microbiome consortia Moore Foundation (2020-2024): $23,000 for archaeal evolutionary tools Chinese Scholarship Council (2022-2026): Artificial community construction The Flow Cytometry Working Group under her leadership at UFZ develops standardized mock communities (Nature Protocols 2020), automated analysis tools (flowEMMi), and cytometric barcoding methods. It collaborates with Leipzig University, Technical University Dresden, and international partners including UC Santa Barbara, driving innovations in real-time environmental monitoring and wastewater treatment optimization.

Klaus Ingemann PedersenView profile

Professor

• Wireless Communication Networks
• Dependable Wireless Communications
• 5G-Advanced Technology
• +10 more

Klaus Ingemann Pedersen is a Professor in the Department of Electronic Systems at the Technical Faculty of IT and Design, Aalborg University, Denmark. His research focuses on wireless communication networks and dependable wireless communications with substantial contributions to 5G-Advanced and 6G technologies. His research interests include: Wireless Communication Networks Dependable Wireless Communications 5G-Advanced Technology 6G Networks Radio System-Level Simulations Ultra-Reliable Low Latency Communication Heterogeneous Networks Professor Pedersen's recent work demonstrates cutting-edge research in next-generation wireless systems, with particular emphasis on deep reinforcement learning applications, link adaptation techniques, and system-level simulations. His publications show consistent high-impact output with 152 total publications spanning from 2012 to 2025, reflecting ongoing productivity and relevance in the rapidly evolving field of wireless communications. His notable achievements include: 5G-prisen (The 5G Award) received on October 23, 2019, shared with E. Mogensen and I.R. Larrad Professor Pedersen has supervised 8 PhD students according to institutional records. His research has practical applications in wireless communication, as evidenced by his involvement in patented technology 'Method and apparatus for wireless communication' which delivers social impact and quality of life improvements. His work shows strong international collaboration across multiple countries as indicated by the research network visualization.

Kang ChenView profile

Professor

• Immunology
• Cancer Immunology
• Reproductive Immunology
• +6 more

Professor Kang Chen is a faculty member at the Wayne State University School of Medicine with joint appointments in the Department of Obstetrics and Gynecology , Biochemistry, Microbiology and Immunology , Oncology , and the Center for Molecular Medicine and Genetics . He co-chairs the Immunology Focus Group across Wayne State University, Karmanos Cancer Institute, and Henry Ford Health. PhD : Weill Cornell Medicine, Memorial Sloan-Kettering Cancer Center, Hospital for Special Surgery BSc (First-Class Honours): National University of Singapore Dr. Chen's research focuses on immune regulation of cancer , reproductive disorders , and mucosal immunity . His lab investigates antibody diversification mechanisms in B cells, immunoglobulin class switching and somatic hypermutation dysregulation in diseases, and maternal-fetal immune interactions affecting pregnancy outcomes. Recent publications highlight his work on WWC proteins in tumor suppression (2025), gene therapy for mesothelioma (2024), IgD-basophil interactions (2023), Maspin in cancer stem cell regulation (2022), and preterm labor immunoprotection (2017). His studies span immunology , oncology , and reproductive medicine . Scientific Awards American Association of Immunologists Travel Awards (2023, 2025) College Teaching Awards (2020, 2017) Research Excellence Award (2016) Burroughs Wellcome Fund Investigator (2014) NIH MIST Young Investigator Award (2013) Dr. Chen teaches Immunology , Cancer Immunotherapy , and Reproductive Biology courses at Wayne State University. His lab collaborates with academic and clinical partners across institutions, leveraging molecular, cellular, and animal model approaches to develop novel therapeutics for cancer and immune-related reproductive disorders. As principal investigator, he leads studies on maternal-fetal immune crosstalk , antibody diversification , and mucosal immunology , with patents in therapeutic antibody generation and preterm labor prevention .

Attila KumanovicsView profile

Clinical Professor

• Molecular genetic pathology
• Immunology
• Primary immunodeficiency diseases
• +5 more

Attila Kumanovics, M.D., is a Clinical Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, USA. A board-certified clinical pathologist (American Board of Pathology, 2011) and molecular genetic pathologist (American Board of Pathology, 2012), he focuses on molecular and cellular immunology testing and the diagnosis of inborn errors of immunity. Education & Certifications Board Certification – Molecular Genetic Pathology, American Board of Pathology, 2012 Board Certification – Clinical Pathology, American Board of Pathology, 2011 M.D. (institution & year not specified in text) Research Focus Dr. Kumanovics’ research integrates cutting-edge molecular genetic techniques with clinical immunology to uncover the genetic underpinnings of primary immunodeficiency diseases. His work spans: Molecular Genetic Pathology: Development and validation of next-generation sequencing assays for HLA typing and immunodeficiency gene panels. Primary Immunodeficiencies: Identification and characterization of novel monogenic defects affecting immune cell development and function. Diagnostic Immunology: Optimization of flow-cytometric and functional assays for immune cell subset analysis and autoantibody detection. Publication Impact With 61 peer-reviewed publications from 1995 to 2025, Dr. Kumanovics has produced an influential body of work that advances both basic understanding and clinical practice. Landmark papers include the 2024 Science Advances study on ITPR3 variants, multi-author reviews on primary immunodeficiency diagnostic guidelines, and technical articles on next-generation HLA typing and flow cytometry. His research trajectory illustrates a steady evolution from foundational immunology and mouse models toward high-resolution genomic diagnostics and international consensus guidelines. Scientific Awards & Recognition Board Certification – Molecular Genetic Pathology, American Board of Pathology (2012) Board Certification – Clinical Pathology, American Board of Pathology (2011) Active contributor to American Academy of Allergy, Asthma & Immunology working groups Collaborations & Teams Dr. Kumanovics collaborates extensively within Mayo Clinic’s Department of Laboratory Medicine and Pathology, serving as a key resource for molecular genetic pathology consultations. He participates in multi-institutional consortia such as the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology, co-authoring diagnostic frameworks that are used worldwide. Details of specific laboratories or grant funding were not disclosed in the provided text.

Paul NurseView profile

Professor

• Cell biology
• Cell cycle regulation
• Genomics
• +3 more

Sir Paul Nurse is a Nobel Prize-winning British geneticist and cell biologist who serves as Chief Executive Officer of the Francis Crick Institute and previously served as President of the Royal Society and Rockefeller University. His groundbreaking research on the cell cycle, particularly in fission yeast, has fundamentally advanced our understanding of cell division and cancer biology. Education: PhD in Biology, University of East Anglia (1973) BSc in Biology, University of Birmingham (1970) Research Interests: Paul Nurse's laboratory focuses on understanding how cells grow and divide through the cell cycle, a complex process involving cell growth, DNA synthesis, and mitosis. Using fission yeast as a model organism, his research investigates the regulatory networks that control cell cycle progression, particularly how cells monitor their own size and coordinate cell cycle transitions. His work has broader significance for understanding human cellular controls and cancer development. Awards and Recognition: Nobel Prize in Physiology or Medicine (2001) Royal Medal (1995) Copley Medal (2005) Albert Lasker Award for Basic Medical Research (1998) Knight Bachelor (1999) French Legion d'Honneur (2002) Order of the Rising Sun (2018) Albert Einstein World Award of Science (2013) Leadership and Advisory Roles: Chief Executive Officer, Francis Crick Institute (2010-present) President, Royal Society (2010-2015) President, Rockefeller University (2003-2010) Chief Executive, Cancer Research UK (2002-2003) Director General, Imperial Cancer Research Fund (1996-2002) Chief Scientific Adviser, European Commission (2017-present)